Cvs
Sodium Chloride, Sodium Bicarbonate
Cvs Pharmacy, Inc.
Human Otc Drug
NDC 69842-453Cvs also known as Sodium Chloride, Sodium Bicarbonate is a human otc drug labeled by 'Cvs Pharmacy, Inc.'. National Drug Code (NDC) number for Cvs is 69842-453. This drug is available in dosage form of Kit. The names of the active, medicinal ingredients in Cvs drug includes . The currest status of Cvs drug is Active.
Drug Information:
| Drug NDC: | 69842-453 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Cvs |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Sodium Chloride, Sodium Bicarbonate |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Cvs Pharmacy, Inc. |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Kit |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | |
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | |
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 24 Apr, 2017 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 21 Dec, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | CVS Pharmacy, Inc.
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| RxCUI: | 1542919
|
| The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UNII: | |
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 69842-453-10 | 1 KIT in 1 KIT (69842-453-10) * 30 PACKET in 1 KIT / 3000 mg in 1 PACKET (69842-324-01) | 24 Apr, 2017 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose nasal wash
Product Elements:
Cvs sodium chloride, sodium bicarbonate cvs sodium bicarbonate, sodium chloride water sodium bicarbonate bicarbonate ion sodium chloride chloride ion
Indications and Usage:
Uses temporarily relieves symptoms associated with sinusitis, cold, flu or allergies: â¢sneezing â¢runny nose â¢nasal stuffiness â¢post nasal drip â¢removes inhaled irritants (dust, pollen) â¢promotes nasal and sinus drainage â¢helps reduce swelling of nasal membranes â¢moisturizes dry nasal passages
Warnings:
Warnings ⢠stop use and ask a doctor if washing is uncomfortable or symptoms are not relieved ⢠do not use unfiltered tap water, see instructions inside box for proper water sources. ⢠do not use if nasal passages are completely blocked or if you have an ear infection or blocked ears. when using this product: use by only one person wash with soap and water after each use top rack of dishwasher safe do not heat in microwave
Dosage and Administration:
Directions adults and children 4 years and over: use 1-2 packets per 8 fl oz (240 ml) up to every 2 hours as needed children under 4 years: consult a physician see enclosed instruction sheet for complete directions and proper use
Spl Patient Package Insert:
Ins
Inx2
Package Label Principal Display Panel:
Cvs
Further Questions:
Questions? 1-888-547-5492